RapidPulse
RapidPulse
  • Home
  • Technology
  • Team
  • News
  • Clinical Trials
  • Investors
  • Careers
  • Contact
  • More
    • Home
    • Technology
    • Team
    • News
    • Clinical Trials
    • Investors
    • Careers
    • Contact
  • Sign In

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out


Signed in as:

filler@godaddy.com

  • Home
  • Technology
  • Team
  • News
  • Clinical Trials
  • Investors
  • Careers
  • Contact

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

RapidPulse Pivotal Clinical Trial

The pivotal study of RapidPulse® as a frontline approach for patients with acute ischemic stroke due to large vessel occlusions.

The RapidPulse® system is not yet cleared by the US FDA

The system is not yet available for commercial sale.

Study Objectives

Primary Effectiveness Endpoint

Key Secondary Effectiveness Endpoints

Primary Effectiveness Endpoint

 First Pass Reperfusion Effect (FPE) as defined by mTICI ≥ 2c after one reperfusion attempt as assessed by an independent Core lab.

Primary Safety Endpoint

Key Secondary Effectiveness Endpoints

Primary Effectiveness Endpoint

Rate of symptomatic intracranial hemorrhage (sICH) at 24 hours post-thrombectomy as assessed by an independent Clinical Events Committee.

Key Secondary Effectiveness Endpoints

Key Secondary Effectiveness Endpoints

Key Secondary Effectiveness Endpoints

 Frontline mTICI ≥ 2b after up to 3 passes (without rescue) as assessed by independent core lab.

90 day modified Rankin Scale (mRS).

Key Results from Early Clinical Use & Trials

Abstract presented at the Society of Neurointerventional Surgery Annual Meeting - 2022


Bajrami, A., et al. “RapidPulse cyclic aspiration system for acute ischemic stroke due to large vessel occlusions.” Interventional Neuroradiology. March 2024. doi:10.1177/15910199241239094


Data presented at the Society of Vascular and Interventional Neurology meeting - 2024


Copyright © 2021 RapidPulse, Inc. - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept